Portfolio company
Epix Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops temperature-controlled cardiac ablation systems for clinicians to treat patients suffering from heart rhythm disorders such as atrial fibrillation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kardium
This company develops a mapping and pulsed field ablation system used by physicians to treat patients with atrial fibrillation.
Argá Medtech
This company develops non-thermal cardiac ablation systems and proprietary catheters for healthcare providers to treat atrial fibrillation and other cardiac arrhythmias.
Affera
This medical technology company develops integrated cardiac mapping and ablation systems for electrophysiologists to treat patients suffering from heart rhythm disorders.
EP Solutions SA
This company develops non-invasive cardiac mapping technology to assist physicians in diagnosing rhythm disturbances and improving outcomes for heart failure patients.
S4 Medical
This company develops an esophageal deviation device to protect patients from thermal injury during cardiac ablation procedures for atrial fibrillation.
ChamberTech
The company develops a hybrid ablation catheter system to treat patients with persistent atrial fibrillation by targeting both endocardial and epicardial heart surfaces.
Securus Medical Group
This company develops thermal monitoring systems for measuring esophageal temperature during cardiac ablation procedures to assist clinicians and surgeons.
Adagio Medical
The company develops ultra-low temperature cryoablation catheters and systems used by hospitals to treat patients with cardiac arrhythmias and ventricular tachycardia.
